Boys Town National Research Hospital in Nebraska becomes first activated site in study targeting four rare pediatric lysosomal storage disorders and has now initiated patient screening as Polaryx advances toward first pa
Why Is PLYX (PLYX) Stock Down Today?
Updated Nov 19, 2026 7:40 PM ET · Prev Close $1.61
Session Regime & Catalyst Assessment
68% Signal ConvictionPLYX Pulling Back 6.21% on 0.62x Relative Volume
Plyx (Plyx) is pulling back 6.21% (-$0.10) to $1.51 on 0.62x average session volume. Relative to benchmarks, PLYX is lagging the S&P 500 by -4.25%. 14-day RSI stands at 31.3, keeping momentum in a bearish regime.
Boys Town National Research Hospital in Nebraska becomes first activated site in study targeting four rare pediatric lysosomal storage disorders and has now initiated patient screening as Polaryx advances toward first pa
Price ($1.51) trades relative to 20-day SMA ($1.78) and 50-day SMA ($1.93).
Market & Sector Relative Strength
PLYX lagging the S&P 500 by -4.25%Options Flow & Execution Desk
Recent PLYX Catalyst Headlines
Verified WireDr. Charlton brings over 15 years of rare disease and pediatric drug development experience including CMO and clinical development roles Appointment further strengthens clinical leadership and execution capabilities ahea
Company on track to initiate Soteria trial in the second half of 2026 Clinical development activities advancing following FDA authorization, CRO engagement and Fast Track Designation across all four planned indication PA
Paramus, Nj, May 28, 2026 Globe Newswire -- Polaryx Therapeutics, Inc. the Company or Polaryx Nasdaq PLYX , a clinical-stage biotechnology company developing novel, disease-modifying therapies for rare, pediatric lysosom
1–3 Day Expected Range & Key Level
48% Follow-ThroughMonitor volume expansion above 1.5x RVOL around $1.51 (session support) for directional breakout confirmation.
Technical Regime (PLYX)
BEARISH MA TRENDAbout PLYX
Get Instant PLYX Catalyst Alerts
Receive an email alert when PLYX triggers an unusual volume breakout, options sweep, or rating shift.
Other Liquid Stocks Moving Today
All Today's MoversPLYX Session & Catalyst FAQ
Why is PLYX stock down today?
Plyx (Plyx) is pulling back 6.21% (-$0.10) to $1.51 on 0.62x average session volume. Relative to benchmarks, PLYX is lagging the S&P 500 by -4.25%. 14-day RSI stands at 31.3, keeping momentum in a bearish regime.
Is PLYX stock a buy or sell right now?
Today's session carries a 68% catalyst conviction score on 0.62x relative volume (low participation). Our multi-factor model currently rates PLYX as HOLD. Review full valuation, quality, and timing signals on the PLYX Buy or Sell Decision Brief →
What is PLYX's intrinsic value and expected trading range?
At $1.51, PLYX's modeled 1-to-3 session range is $1.43 – $1.59, with a key inflection level at $1.51 (session support). Compare current price against multi-year cash flow projections in the PLYX Intrinsic Value & DCF Model → and Market Cycle Phase Tracker →
What do RSI and moving averages signal for PLYX?
RSI at 31.3 reflects soft below-midline momentum. PLYX trades at $1.51 relative to its 20-day SMA ($1.78) and 50-day SMA ($1.93), reflecting a bearish moving-average structure.
Tradestie Flagship Research & Market Hubs
Live institutional catalyst tape ranking liquid gainers, losers, options sweeps, and RVOL surges.
Track spot H100/B200 compute rental rates and frontier LLM inference token economics.
Wafer yield, CoWoS packaging, and HBM bill-of-materials teardown models across AI accelerators.
Monitor engineering velocity and upstream foundry wafer demand inflections across tech leaders.
Live conviction tracking, invalidation guardrails, and thesis health checks on flagship ideas.
Backtest-validated unusual options positioning and open-interest accumulation setups.
Daily ranked quantitative leaderboard with audited forward-return track record vs S&P 500.
High-yield, quality-screened cash-secured put and put-spread income candidates.